A carregar...

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma

Drug combination therapies remain pivotal for the treatment of heterogeneous malignancies, such as glioblastomas. Here, we show a novel lethal interaction between Bcl-xL and c-myc inhibition accomplished by bromodomain protein inhibitors. Established, patient-derived xenograft and stem cell-like gli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ishida, Chiaki Tsuge, Bianchetti, Elena, Shu, Chang, Halatsch, Marc-Eric, Westhoff, M. Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444687/
https://ncbi.nlm.nih.gov/pubmed/28418907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!